Demineralized bone fibers and preparation thereof

Patent metadata

Field	Value
Publication number	US-11033656-B2
Application number	US-201716309505-A
Country	US
Kind code	B2
Filing date	Jun 13, 2017
Priority date	Jun 13, 2016
Publication date	Jun 15, 2021
Grant date	Jun 15, 2021

Abstract

The present invention provides demineralized bone fibers exhibiting optimal handling properties (e.g., high moldability and low elastic modulus) and biological activities (e.g., osteoinductivity) as well as non-demineralized bone fibers useful for preparing the demineralized bone fibers. A well-controlled demineralization process for preparing the demineralized bone of fibers is also provided. Products comprising the demineralized bone fibers and uses thereof are further provided.

First claim

What is claimed:

1. A method for preparing a demineralized bone graft, wherein the demineralized bone graft has a residual calcium content of less than 6 wt % based on the dry weight of the demineralized bone graft, comprising subjecting a non-demineralized bone graft to a single incubation in an acid solution for no more than 300 seconds, wherein the acid solution has a pH of 0-4, and adding an effective amount of a buffer to the acid solution after the single incubation, whereby the pH of the resulting solution is adjusted to 2.5-7.0 within 90 seconds after the addition of the buffer.

2. The method of claim 1 , wherein the non-demineralized bone graft comprises bone fibers, bone particles, bone sheets, bone cubes, bone shafts, or a combination thereof.

3. The method of claim 1 , wherein the non-demineralized bone graft comprises non-demineralized bone fibers, and wherein the demineralized bone graft comprises demineralized bone fibers.

4. The method of claim 3 , wherein the demineralized bone fibers are osteoinductive.

5. The method of claim 3 , wherein the non-demineralized bone fibers have an average shortest dimension of less than 200 μm.

6. The method of claim 3 , wherein the demineralized bone fibers have an elastic modulus of less than 100.00 kPa.

7. The method of claim 3 , further comprising storing the demineralized bone fibers in a storage solution, wherein the storage solution is glycerol, a buffer, or a cryopreservation solution.

8. The method of claim 3 , further comprising drying the demineralized bone fibers.

9. The method of claim 3 , further comprising releasing at least 75 wt % of calcium in the non-demineralized bone fibers.

10. A composition comprising the demineralized bone fibers produced by the method of claim 3 , wherein the demineralized bone fibers have a specific surface area of 185-5,550 cm 2 /cm 3 .

11. An implant comprising the composition of claim 10 .

12. A package comprising the composition of claim 10 .

13. A method for promoting osteoinductivity, osteoconductivity, chondroinductivity, chondroconductivity, or fibrochondral differentiation in entheses, comprising incubating cells with an effective amount of the composition of claim 10 .

14. A method for promoting cell attachment, proliferation, maintaining a differentiation state or preventing de-differentiation of cells, comprising incubating cells with an effective amount of the composition of claim 10 .

15. A method for promoting osteogenesis, chondrogenesis, or fibrocartilage tissue genesis in cells, comprising incubating the cells with an effective amount of the composition of claim 10 .

16. A method for treating a tissue or organ defect in a subject, comprising applying to the site of the defect an effective amount of the composition of claim 10 .

17. A composition comprising the demineralized bone graft produced by the method of claim 3 , wherein the demineralized bone fibers have a specific surface area of 185-5,550 cm 2 /cm 3 .

18. The method of claim 3 , wherein the non-demineralized bone fibers are generated by a Computer Numerical Control (CNC) machine using a chip load of 0.004″-0.011″.

19. A composition comprising demineralized bone fibers having a residual calcium content of less than 6 wt % based on the dry weight of the demineralized bone fibers, wherein the demineralized bone fibers are osteoinductive, and wherein the demineralized bone fibers have an elastic modulus of less than 100.00 kPa, wherein the demineralized bone fibers have a specific surface area of 185-5,550 cm 2 /cm 3 .

20. A composition comprising demineralized bone fibers having a residual calcium content of between 0.5-6 wt % based on the dry weight of the demineralized bone fibers, wherein the demineralized bone fibers are osteoinductive, wherein the demineralized bone fibers have a specific surface area 185-5,550 cm 2 /g.

Assignees

• Lifenet Health

Inventors

• Chen Silvia
• Cleavenger Grant
• Phelps Dennis
• Wralstad Evans
• Gjurich Breanne
• Johnson Austin
• Sampson Alana
• Entsminger Adam
• Chen Jingsong

Classifications

• A61L27/3847

  Bones · CPC title

• A61P19/08 Primary

  for bone diseases, e.g. rachitism, Paget's disease · CPC title

• A61L27/3687

  characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents · CPC title

• A61L27/3821

  Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells · CPC title

• A61L2430/02

  for reconstruction of bones; weight-bearing implants · CPC title